SFG
DGX icon

SevenBridge Financial Group’s Quest Diagnostics DGX Stock Holding History

SevenBridge Financial Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-289
Closed -$27K – 626
2017
Q3 		$27K Hold
289
– – 0.02% 332
2017
Q2 		$32K Hold
289
– – 0.02% 322
2017
Q1 		$28K Hold
289
– – 0.02% 326
2016
Q4 		$24K Hold
289
– – 0.02% 339
2016
Q3 		$24K Sell
289
-34
-11% -$2.85K 0.02% 337
2016
Q2 		$26K Buy
+323
New +$24.6K 0.02% 372

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

SevenBridge Financial Group's DGX Position: Q4 2017 in Review

SevenBridge Financial Group sold out of Quest Diagnostics (DGX) in Q4 2017, closing a stake of 289 shares — an estimated $27K sold.

SevenBridge Financial Group first reported a position in DGX in Q2 2016 and held it in 6 quarters. The position peaked at $32K in Q2 2017. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.

  • SevenBridge Financial Group reported no remaining Quest Diagnostics position as of Q4 2017 after selling out during the quarter.
  • SevenBridge Financial Group sold 289 Quest Diagnostics shares in Q4 2017, an estimated $27K.
  • SevenBridge Financial Group first reported a position in Quest Diagnostics in Q2 2016 and held it in 6 quarters.
  • SevenBridge Financial Group's Quest Diagnostics position peaked at $32K in Q2 2017.
  • 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.

Based on SevenBridge Financial Group's 13F filing for Q4 2017, filed 20 Feb 2018.